rs2376805
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000815.5(GABRD):c.69-19G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.82 in 1,568,616 control chromosomes in the GnomAD database, including 528,265 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.81 ( 50323 hom., cov: 36)
Exomes 𝑓: 0.82 ( 477942 hom. )
Consequence
GABRD
NM_000815.5 intron
NM_000815.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.221
Genes affected
GABRD (HGNC:4084): (gamma-aminobutyric acid type A receptor subunit delta) Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. The GABA-A receptor is generally pentameric and there are five types of subunits: alpha, beta, gamma, delta, and rho. This gene encodes the delta subunit. Mutations in this gene have been associated with susceptibility to generalized epilepsy with febrile seizures, type 5. Alternatively spliced transcript variants have been described for this gene, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 1-2024923-G-A is Benign according to our data. Variant chr1-2024923-G-A is described in ClinVar as [Benign]. Clinvar id is 256824.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-2024923-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.825 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRD | NM_000815.5 | c.69-19G>A | intron_variant | ENST00000378585.7 | NP_000806.2 | |||
GABRD | XM_017000936.2 | c.755G>A | p.Arg252Gln | missense_variant | 1/8 | XP_016856425.1 | ||
GABRD | XM_011541194.4 | c.108-19G>A | intron_variant | XP_011539496.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRD | ENST00000378585.7 | c.69-19G>A | intron_variant | 1 | NM_000815.5 | ENSP00000367848 | P1 |
Frequencies
GnomAD3 genomes AF: 0.813 AC: 123660AN: 152152Hom.: 50293 Cov.: 36
GnomAD3 genomes
AF:
AC:
123660
AN:
152152
Hom.:
Cov.:
36
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.803 AC: 200186AN: 249240Hom.: 80725 AF XY: 0.807 AC XY: 108942AN XY: 135064
GnomAD3 exomes
AF:
AC:
200186
AN:
249240
Hom.:
AF XY:
AC XY:
108942
AN XY:
135064
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.821 AC: 1162309AN: 1416348Hom.: 477942 Cov.: 23 AF XY: 0.820 AC XY: 579931AN XY: 707314
GnomAD4 exome
AF:
AC:
1162309
AN:
1416348
Hom.:
Cov.:
23
AF XY:
AC XY:
579931
AN XY:
707314
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.813 AC: 123740AN: 152268Hom.: 50323 Cov.: 36 AF XY: 0.811 AC XY: 60364AN XY: 74452
GnomAD4 genome
AF:
AC:
123740
AN:
152268
Hom.:
Cov.:
36
AF XY:
AC XY:
60364
AN XY:
74452
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2631
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Epilepsy, idiopathic generalized, susceptibility to, 10 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Idiopathic generalized epilepsy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at